ClinicalTrials.gov
ClinicalTrials.gov Menu

Treosulfan/Fludarabine/Low Dose TBI as a Preparative Regimen for Children With AML/MDS Undergoing Allo HCT

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01772953
Recruitment Status : Completed
First Posted : January 21, 2013
Last Update Posted : October 12, 2016
Sponsor:
Collaborators:
National Marrow Donor Program
Resource for Clinical Investigation in Blood and Marrow Transplantation (RCI BMT)
Pediatric Blood and Marrow Transplant Consortium
St. Baldrick's Foundation
medac GmbH
Information provided by (Responsible Party):
Center for International Blood and Marrow Transplant Research

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2015
  Actual Study Completion Date : August 2015